期刊文献+

红霉素纳米乳的制备及其药效学研究 被引量:8

Study on preparation of erythromycin nanoemulsion and its pharmacy in vitro
下载PDF
导出
摘要 【目的】研制红霉素纳米乳制剂,并检测其体外药效。【方法】利用伪三元相图法,以tween-80为表面活性剂、无水乙醇为助表面活性剂、乙酸乙酯为油相、红霉素原料药为主药,制备红霉素纳米乳,并对其形态特征、稳定性和体外药效进行检测。【结果】红霉素纳米乳的最佳配方(质量分数,%)为:红霉素1%,无水乙醇10%,Tween8030%,乙酸乙酯4.4%,去离子水54.6%。用该配方制备的红霉素纳米乳为澄清透明的液体,透射电镜下观察为球状液滴,粒径为10~100 nm,具有良好的分散性。红霉素纳米乳经高速离心和在-4℃、室温、60℃条件下留样观察,均未见纳米乳发生变化。红霉素纳米乳对耐药金黄色葡萄球菌、溶血性链球菌的最小抑菌浓度分别是0.01563和0.125mg/mL。【结论】研制的红霉素纳米乳为澄清透明的淡黄色液体,稳定性良好,其对耐药金黄色葡萄球菌、溶血性链球菌均有较强的抑菌和杀菌作用。 【Objective】 This research is to study the preparation and pharmacy of Erythromycin Nanoemulsion.【Method】 The Erythromycin Nanoemulsion with suitable surfactant,cosurfactant,oil,water and Erythromycin was prepared by studying the pseudoternary phase diagrams.And its configuration,physical stability and pharmacy in vitro were evaluated.【Result】 The optimal prescription of erythromycin nanoemulsion was erythromycin 1%,adsolute etylalcohol 10%,Tween 80 30%,aceticether 4.4%,deionized water 54.6%.The erythromycin nanoemulsion prepared by the prescription was a kind of clear solution and it presented as small spherical drops under Transmission Electron Microscope(TEM),with the diameter of about 10-100 nm.Erythromycin nanoemulsion was stable after high speed centrifuge and reserving at-4 ℃,room temperature and 60 ℃.The MICs of Erythromycin on Staphylococcus and Streptococcus were respectively 0.015 63 and 0.125 mg/mL.【Conclusion】 The erythromycin nanoemulsion was a kind of clear solution with very good stability.The antibacterial effect of erythromycin nanoemulsion on staphylococcus and streptococcus in vitro was remarkable.
出处 《西北农林科技大学学报(自然科学版)》 CSCD 北大核心 2008年第3期59-63,共5页 Journal of Northwest A&F University(Natural Science Edition)
基金 奶业发展重大关键技术研究与示范项目(2006BAD04A11)
关键词 红霉素 纳米乳 体外药效 erythromycin nanoemulsion pharmacy in vitro
  • 相关文献

参考文献15

二级参考文献33

  • 1纪海英,张钧寿.尼群地平胶囊自乳化释药系统处方优化研究[J].中国药科大学学报,2004,35(3):211-214. 被引量:13
  • 2张莉,向东,洪诤,张志荣.肝靶向去甲斑蝥素微乳的研究[J].药学学报,2004,38(8):650-655. 被引量:52
  • 3曹宗顺,卢凤琦.微乳及其在药物制剂中的应用[J].国外医药(合成药.生化药.制剂分册),1993,14(5):289-293. 被引量:16
  • 4王红喜.微乳制剂的研究进展[J].国外医学(药学分册),1996,23(4):206-211. 被引量:27
  • 5王倩,丁红梅,周海源.微乳相图及工艺研究[J].西北药学杂志,1997,12(2):72-73. 被引量:21
  • 6[1]Campoi-Richards DM, Clissold SP. Famotidine pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome[J]. Drugs, 1986, 32(2):197-221.
  • 7[2]Eisen HJ, Hobbs RE, Davis SF, et al. Safety, tolerability,and efficacy of cyclosporine microemulsion in heart transplant recipients [J].Transplantation, 2001, 71(1): 70-8.
  • 8[3]Lyons KC, Charman WN, Miller R, et al. Factors limiting the oral bioavailability of N-acetylglucosaminyl-N-acetylmuramyl dipeptide(GMDP) and enhancement of absorption in rats by delivery in a water-in-oil microemulsion[J]. Int J Pharm, 2000,199(1): 17-28.
  • 9[4]Kim HJ, Yoon KA, Hahn M, et al. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone[J]. Drug Dev Ind Pharm, 2000, 26(5): 523-9.
  • 10[7]Cortesi R, Esposito E, Maitra A, et al. Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and microemulsion[J]. Int J Pharm, 1997, 159: 95-103.

共引文献169

同被引文献70

引证文献8

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部